Clinical Trial Update: Diacutaneous Fibrolysis and Patellofemoral Pain Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating diacutaneous fibrolysis for patellofemoral pain syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Patellofemoral Pain Syndrome

Snippet

Sponsor: Universidad de Zaragoza | Conditions: Patellofemoral Pain Syndrome | Phase 3 | Status: COMPLETED